109 related articles for article (PubMed ID: 15166628)
1. Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells.
Serpe L; Laurora S; Pizzimenti S; Ugazio E; Ponti R; Canaparo R; Briatore F; Barrera G; Gasco MR; Bernengo MG; Eandi M; Zara GP
Anticancer Drugs; 2004 Jun; 15(5):525-36. PubMed ID: 15166628
[TBL] [Abstract][Full Text] [Related]
2. Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells.
Dianzani C; Cavalli R; Zara GP; Gallicchio M; Lombardi G; Gasco MR; Panzanelli P; Fantozzi R
Br J Pharmacol; 2006 Jul; 148(5):648-56. PubMed ID: 16702992
[TBL] [Abstract][Full Text] [Related]
3. Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines.
Foglietta F; Serpe L; Canaparo R; Vivenza N; Riccio G; Imbalzano E; Gasco P; Zara GP
J Pharm Pharm Sci; 2014; 17(2):231-47. PubMed ID: 24934552
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: evaluation of antiproliferative activity and apoptosis induction.
Salomone B; Ponti R; Gasco MR; Ugazio E; Quaglino P; Osella-Abate S; Bernengo MG
Clin Exp Metastasis; 2000; 18(8):663-73. PubMed ID: 11827070
[TBL] [Abstract][Full Text] [Related]
5. Improved In Vitro Antileukemic Activity of All-Trans Retinoic Acid Loaded in Cholesteryl Butyrate Solid Lipid Nanoparticles.
Silva EL; Lima FA; Carneiro G; Ramos Jonas Periera ; Gomes DA; de Souza-Fagundes EM; Ferreira LA
J Nanosci Nanotechnol; 2016 Feb; 16(2):1291-300. PubMed ID: 27433579
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models.
Minelli R; Occhipinti S; Gigliotti CL; Barrera G; Gasco P; Conti L; Chiocchetti A; Zara GP; Fantozzi R; Giovarelli M; Dianzani U; Dianzani C
Br J Pharmacol; 2013 Sep; 170(2):233-44. PubMed ID: 23713413
[TBL] [Abstract][Full Text] [Related]
7. The effect of formulation and concentration of cholesteryl butyrate solid lipid nanospheres (SLN) on NIH-H460 cell proliferation.
Ugazio E; Marengo E; Pellizzaro C; Coradini D; Peira E; Daidone MG; Gasco MR
Eur J Pharm Biopharm; 2001 Sep; 52(2):197-202. PubMed ID: 11522486
[TBL] [Abstract][Full Text] [Related]
8. Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug.
Rabizadeh E; Shaklai M; Nudelman A; Eisenbach L; Rephaeli A
FEBS Lett; 1993 Aug; 328(3):225-9. PubMed ID: 8348968
[TBL] [Abstract][Full Text] [Related]
9. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity.
Choi YH
Int J Oncol; 2006 Nov; 29(5):1207-13. PubMed ID: 17016653
[TBL] [Abstract][Full Text] [Related]
11. Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug.
Brioschi A; Zara GP; Calderoni S; Gasco MR; Mauro A
Molecules; 2008 Feb; 13(2):230-54. PubMed ID: 18305415
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the effects of butyric acid on cell proliferation, cell cycle distribution and apoptosis.
Kurita-Ochiai T; Hashizume T; Yonezawa H; Ochiai K; Yamamoto M
FEMS Immunol Med Microbiol; 2006 Jun; 47(1):67-74. PubMed ID: 16706789
[TBL] [Abstract][Full Text] [Related]
13. Butyrate induces reactive oxygen species production and affects cell cycle progression in human gingival fibroblasts.
Chang MC; Tsai YL; Chen YW; Chan CP; Huang CF; Lan WC; Lin CC; Lan WH; Jeng JH
J Periodontal Res; 2013 Feb; 48(1):66-73. PubMed ID: 22834967
[TBL] [Abstract][Full Text] [Related]
14. Effects of tachyplesin and n-sodium butyrate on proliferation and gene expression of human gastric adenocarcinoma cell line BGC-823.
Shi SL; Wang YY; Liang Y; Li QF
World J Gastroenterol; 2006 Mar; 12(11):1694-8. PubMed ID: 16586536
[TBL] [Abstract][Full Text] [Related]
15. Tetramethylpyrazine inhibits the proliferation of acute lymphocytic leukemia cell lines via decrease in GSK-3β.
Wang XJ; Xu YH; Yang GC; Chen HX; Zhang P
Oncol Rep; 2015 May; 33(5):2368-74. PubMed ID: 25812605
[TBL] [Abstract][Full Text] [Related]
16. Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid delivery.
Pellizzaro C; Coradini D; Morel S; Ugazio E; Gasco MR; Daidone MG
Anticancer Res; 1999; 19(5B):3921-5. PubMed ID: 10628332
[TBL] [Abstract][Full Text] [Related]
17. Targeting glycosylation pathways and the cell cycle: sugar-dependent activity of butyrate-carbohydrate cancer prodrugs.
Sampathkumar SG; Jones MB; Meledeo MA; Campbell CT; Choi SS; Hida K; Gomutputra P; Sheh A; Gilmartin T; Head SR; Yarema KJ
Chem Biol; 2006 Dec; 13(12):1265-75. PubMed ID: 17185222
[TBL] [Abstract][Full Text] [Related]
18. Neutrophilic differentiation modulates the apoptotic response of HL-60 cells to sodium butyrate and sodium valproate.
Vrba J; Dolezel P; Ulrichova J
Neoplasma; 2010; 57(5):438-48. PubMed ID: 20568898
[TBL] [Abstract][Full Text] [Related]
19. Apogossypolone inhibits cell growth by inducing cell cycle arrest in U937 cells.
Sun J; Li ZM; Hu ZY; Zeng ZL; Yang DJ; Jiang WQ
Oncol Rep; 2009 Jul; 22(1):193-8. PubMed ID: 19513523
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line.
Serpe L; Catalano MG; Cavalli R; Ugazio E; Bosco O; Canaparo R; Muntoni E; Frairia R; Gasco MR; Eandi M; Zara GP
Eur J Pharm Biopharm; 2004 Nov; 58(3):673-80. PubMed ID: 15451544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
